Fayetteville, AR – According to filings with the U.S. Securities and Exchange Commission, OurPharma is raising $12,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Peter Kohler played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About OurPharma
OurPharma is a new FDA-registered 503b outsourcing facility designed to address the need for medications that are in short supply regionally and nationally. The initial focus will be on sterile-to-sterile compounding of injectables and intravenous fluids needed by hospitals, surgery centers and clinics. The founding team anticipates continued growth into manufacturing of medications such as insulin in the future. The OurPharma founders have an extensive background in hospital and healthcare administration, giving them firsthand knowledge of the difficulties caused by drug shortages and the effects on patients.

To learn more about OurPharma, visit http://ourpharma.net/

Contact:
Peter Kohler, Chief Executive Officer
479-871-7341
https://www.linkedin.com/in/peter-o-kohler-73484329/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved